Latest Defense News

Propel Funeral Partners reported a 7.9% revenue increase in FY25, driven by acquisitions and modest organic growth, while maintaining strong cash flow and a solid balance sheet. The company signals continued expansion supported by favorable demographics and a leadership transition.

Southern Cross Gold Consolidated Ltd reports significant high-grade gold and record antimony intersections at its Sunday Creek project, extending mineralization to 560m depth and beyond known boundaries. The dual-commodity profile enhances the project's strategic and economic potential amid rising global antimony demand.

IperionX secures a $12.5 million funding tranche from the U.S. Department of Defense to fast-track expansion of its Virginia titanium manufacturing capacity beyond 1,000 metric tons annually.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

Veris Limited has reported a significant financial turnaround for the year ended June 2025, returning to profitability and boosting earnings, while strategically acquiring Spatial Vision to broaden its geospatial services across Australia.

Ophir High Conviction Fund reported a robust financial year ending June 2025, with net assets rising nearly 15% and operating profit more than doubling. The Fund’s concentrated portfolio strategy delivered a 24% net return, comfortably outperforming its benchmark.

Locksley Resources has partnered with Rice University to pioneer domestic antimony processing in the US, aiming to reduce reliance on foreign supply and support critical defense and energy sectors.

G50 Corp has raised A$10 million through a well-supported institutional placement to fund extensive drilling and metallurgical testing at its Golconda project in Arizona, targeting strategic minerals including gallium.

An independent in vivo study from the University of South Florida reveals ArtemiC™ significantly boosts survival and reduces inflammation in a severe viral model, reinforcing its promise as a novel immunomodulatory therapy.

Perpetual Equity Investment Company Limited reported a net profit of $21.7 million for FY25 and maintained its fully franked dividend at 8.0 cents per share, matching last year’s payout despite portfolio underperformance against the benchmark.

Argo Global Listed Infrastructure Ltd reports a striking jump in full-year profit to $52.2 million and declares a record fully franked dividend, highlighting the resilience of its global infrastructure portfolio amid volatile markets.

Elsight Limited has reported a remarkable 344% jump in first-half revenue to US$4.85 million, significantly narrowing its net loss and securing a substantial US$39 million capital raise to fuel growth.